Diagnostic accuracy of 16S rDNA PCR, multiplex PCR and metagenomic next-generation sequencing in periprosthetic joint infections: a systematic review and meta-analysis

The diagnostic accuracy of 16S rDNA PCR, multiplex PCR (mPCR), and metagenomic next-generation sequencing (mNGS) in periprosthetic joint infections (PJIs) remains unclear. This study aims to evaluate the diagnostic accuracy of 16S rDNA PCR, mPCR, and mNGS in PJI. Data sources: Data sources included...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Clinical microbiology and infection Ročník 31; číslo 7; s. 1115
Hlavní autori: Olearo, Flaminia, Zein, Said El, Portillo, Maria Eugenia, Zapf, Antonia, Rohde, Holger, Berbari, Elie F, Wouthuyzen-Bakker, Marjan
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England 01.07.2025
Predmet:
DNA, Ribosomal - genetics
High-Throughput Nucleotide Sequencing - methods
Humans
Metagenomics - methods
Molecular Diagnostic Techniques - methods
Multiplex Polymerase Chain Reaction - methods
Polymerase Chain Reaction - methods
Prosthesis-Related Infections - diagnosis
Prosthesis-Related Infections - microbiology
RNA, Ribosomal, 16S - genetics
Sensitivity and Specificity
16S rDNA PCR
Multiplex PCR
Metagenomic next-generation sequencing
16S rDNA
Diagnostic accuracy tests
Prosthetic joint infection
ISSN:1469-0691, 1469-0691
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:The diagnostic accuracy of 16S rDNA PCR, multiplex PCR (mPCR), and metagenomic next-generation sequencing (mNGS) in periprosthetic joint infections (PJIs) remains unclear. This study aims to evaluate the diagnostic accuracy of 16S rDNA PCR, mPCR, and mNGS in PJI. Data sources: Data sources included PubMed and Embase (January 1, 2000-March 1, 2024), with no language restrictions. Studies containing sufficient data to construct a 2 × 2 contingency table allowing for sensitivity and specificity calculation were considered. Participants included adults (≥18 years) with PJI and appropriate control groups. Tests included 16S rDNA PCR, mPCR, and mNGS. Diagnosis required adherence to Musculoskeletal Infection Society, Infectious Diseases Society of America, International Consensus Meeting, European Bone and Joint Infection Society criteria. Studies employing alternative author-defined criteria were included only if they did not rely solely on positive cultures to define PJI. Quality Assessment of Diagnostic Accuracy Studies 2 was used. A bivariate model calculated pooled diagnostic odds ratios (DORs), sensitivities, and specificities, each with 95% CIs. Seventy-nine studies were included, comprising 3940 PJI cases and 4700 uninfected controls. Pooled sensitivity/specificity were 80.0% (95% CI, 75.4-84.3%)/94.0% (95% CI, 91-96%) for 16S rDNA PCR; 62.2% (52.5-70.9%)/96.2% (93.2-97.9%) for mPCR; and 88.6% (83.3-92.4%)/93.2% (89.5-95.6%) for mNGS. Notably, mNGS had the highest DOR (105.9; 95% CI, 60-186.9). A sensitivity analysis excluding lower-quality studies resulted in increased DORs for all methods. These molecular techniques display strong diagnostic accuracy for identifying PJI. Although mNGS yielded the highest DOR, numerous technical and practical challenges preclude its routine use for PJI diagnosis. Significant heterogeneity across studies warrants cautious interpretation and underscores the need for future comparative research.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1469-0691
1469-0691
DOI:10.1016/j.cmi.2025.02.022